389650
389650StockKQ
42,750.00 ▲ +5.30%
12 juin 2026
3
389650
42,750.00 ▲ +5.30%
12 juin 2026
389650StockKQ

01 / À propos

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea.

Arberion
Loading market data